154 related articles for article (PubMed ID: 32123755)
1. Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda.
Izudi J; Tamwesigire IK; Bajunirwe F
J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100153. PubMed ID: 32123755
[TBL] [Abstract][Full Text] [Related]
2. Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: a retrospective cohort study.
Izudi J; Tamwesigire IK; Bajunirwe F
BMC Public Health; 2020 Apr; 20(1):501. PubMed ID: 32295549
[TBL] [Abstract][Full Text] [Related]
3. Increase in rifampicin resistance among people previously treated for TB.
Izudi J; Bajunirwe F; Cattamanchi A
Public Health Action; 2023 Mar; 13(1):4-6. PubMed ID: 37152209
[TBL] [Abstract][Full Text] [Related]
4. Low treatment success rate among previously treated persons with drug-susceptible pulmonary tuberculosis in Kampala, Uganda.
Izudi J; Okello G; Bajunirwe F
J Clin Tuberc Other Mycobact Dis; 2023 Aug; 32():100375. PubMed ID: 37214160
[TBL] [Abstract][Full Text] [Related]
5. Association between GeneXpert Diagnosis and Same-Day Initiation of Tuberculosis Treatment in Rural Eastern Uganda.
Izudi J; Tamwesigire IK; Bajunirwe F
Am J Trop Med Hyg; 2020 Oct; 103(4):1447-1454. PubMed ID: 32783795
[TBL] [Abstract][Full Text] [Related]
6. Sputum smear non-conversion among adult persons with bacteriologically confirmed pulmonary tuberculosis in rural eastern Uganda.
Izudi J; Tamwesigire IK; Bajunirwe F
J Clin Tuberc Other Mycobact Dis; 2020 Aug; 20():100168. PubMed ID: 32529053
[TBL] [Abstract][Full Text] [Related]
7. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L
Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619
[TBL] [Abstract][Full Text] [Related]
8. Complete sputum smear monitoring among adults with pulmonary tuberculosis in central Uganda: evidence from a retrospective cohort study.
Nsubuga R; Adrawa N; Okoboi S; Komuhangi A; Izudi J
BMC Infect Dis; 2022 Feb; 22(1):191. PubMed ID: 35216577
[TBL] [Abstract][Full Text] [Related]
9. Use of GeneXpert Mycobacterium tuberculosis/rifampicin for rapid detection of rifampicin resistant Mycobacterium tuberculosis strains of clinically suspected multi-drug resistance tuberculosis cases.
Guenaoui K; Harir N; Ouardi A; Zeggai S; Sellam F; Bekri F; Cherif Touil S
Ann Transl Med; 2016 May; 4(9):168. PubMed ID: 27275481
[TBL] [Abstract][Full Text] [Related]
10. Treatment supporters and level of health facility influence completion of sputum smear monitoring among tuberculosis patients in rural Uganda: A mixed-methods study.
Izudi J; Tamwesigire IK; Bajunirwe F
Int J Infect Dis; 2020 Feb; 91():149-155. PubMed ID: 31821894
[TBL] [Abstract][Full Text] [Related]
11. HIV-Negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A Clinical Retrospective Investigation Study from a National Tuberculosis Clinical Research Center.
Ma J; Liu H; Wang J; Li W; Fan L; Sun W
Infect Drug Resist; 2022; 15():1155-1165. PubMed ID: 35340674
[TBL] [Abstract][Full Text] [Related]
12. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China.
Liu Z; Zhang M; Wang J; Chen S; Wu B; Zhou L; Pan A; Wang W; Wang X
Biomed Res Int; 2020; 2020():3159482. PubMed ID: 32104686
[TBL] [Abstract][Full Text] [Related]
15. Chest X-ray findings in drug-sensitive and drug-resistant pulmonary tuberculosis patients in Uganda.
Oriekot A; Sereke SG; Bongomin F; Bugeza S; Muyinda Z
J Clin Tuberc Other Mycobact Dis; 2022 May; 27():100312. PubMed ID: 35355939
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
[TBL] [Abstract][Full Text] [Related]
17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
19. Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance dataĀ 2014-2015.
Al Ammari M; Al Turaiki A; Al Essa M; Kashkary AM; Eltigani SA; Ahmed AE
Antimicrob Resist Infect Control; 2018; 7():12. PubMed ID: 29387346
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes of multi drug resistant and rifampicin resistant Tuberculosis in Zimbabwe: A cohort analysis of patients initiated on treatment during 2010 to 2015.
Matambo R; Takarinda KC; Thekkur P; Sandy C; Mharakurwa S; Makoni T; Ncube R; Charambira K; Zishiri C; Ngwenya M; Nyathi S; Chiteka A; Chikaka E; Mutero-Munyati S
PLoS One; 2020; 15(4):e0230848. PubMed ID: 32353043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
